| Adrenaline (10 µg/kg) |
|
IV/IO, IM, ET |
Cardiac arrest, bradycardia with poor perfusion, anaphylaxis (1 µg/kg IV) |
| Amiodarone (5 mg/kg) |
|
IV/IO |
Ventricular fibrillation or pulseless ventricular tachycardia
unresponsive to defibrillation and CPR |
| Defibrillation (4 j/kg) |
|
External pads |
Ventricular fibrillation or pulseless ventricular tachycardia |
| Cardioversion (1 j/kg) |
|
External pads |
Synchronised Shock, 1.0 joules/kg escalating to 2.0 joules/kg if unsuccessful |
| Atropine (20 µg/kg) |
|
IV/IO |
Bradycardia (after adequate ventilation and oxygenation),
pulseless electrical activity (PEA) with suspected vagal tone |
| Adenosine (100 µg/kg) |
|
Intravenous |
SVT, up to 1 year: 150 µg\kg, increase 50-100 µg\kg
every 1-2 min. Maximum single dose: Neonates 300
µg\kg, Infants 500 µg\kg |
| Magnesium (25-50 mg\kg) |
|
Intravenous |
in Torsades de
pointes VT, maximum per dose 2 g to be given over 10-15 min, may
be repeated once if necessary |
| Calcium Gluconate (0.5 ml/kg) |
|
Intravenous |
Hypocalcaemia, hyperkalaemia (max dose 20 mL);
IV over 2-5 min if unstable, over 15-20 min if stable |
| Fluid bolus (10 ml/kg) |
|
Intravenous |
Balanced isotonic crystalloid or 0.9% Saline |
| Gucose (2 ml/kg) |
|
Intravenous |
Glucose 10% |
| Sodium bicarbonate (1 mmol/kg) |
|
Intravenous |
Sodium Bicarbonate 8.4%, for infants under 3-month-old use 4.2% (2 ml/kg) |